Currency in USD
Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 5 | 5 | 3 | 5 |
Avg. Estimate | 2.86 | 3.32 | 11.46 | 11.76 |
Low estimate | 2.58 | 2.66 | 11.25 | 11 |
High estimate | 3.18 | 4.45 | 11.6 | 12.61 |
Year ago EPS | 3.31 | 3.34 | 14.42 | 11.46 |
Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 685.55M | 667.09M | 2.68B | 2.72B |
Low estimate | 682.48M | 628M | 2.67B | 2.65B |
High estimate | 687.96M | 703.9M | 2.68B | 2.79B |
Year ago sales | 730.29M | 676.84M | 2.8B | 2.68B |
Sales growth (year/est) | -6.10% | -1.40% | -4.50% | 1.70% |
Earnings history | 30/12/2022 | 30/03/2023 | 29/06/2023 | 29/09/2023 |
---|
Est. EPS | 3.45 | 3.54 | 2.68 | 2.78 |
Actual EPS | 3.31 | 3.34 | 3 | 2.33 |
Difference | -0.14 | -0.2 | 0.32 | -0.45 |
Surprise % | -4.10% | -5.60% | 11.90% | -16.20% |
EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|
Current estimate | 2.86 | 3.32 | 11.46 | 11.76 |
7 days ago | 2.86 | 3.32 | 11.46 | 11.76 |
30 days ago | 3.04 | 3.5 | 11.46 | 11.74 |
60 days ago | 3.68 | 4.1 | 12.87 | 14.33 |
90 days ago | 3.73 | 4.02 | 12.94 | 14.45 |
EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -13.60% | N/A | N/A | N/A |
Next qtr. | -0.60% | N/A | N/A | N/A |
Current year | -20.50% | N/A | N/A | N/A |
Next year | 2.60% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 19.72% | N/A | N/A | N/A |